Cargando…
Trial protocol OPPTIMUM– Does progesterone prophylaxis for the prevention of preterm labour improve outcome?
BACKGROUND: Preterm birth is a global problem, with a prevalence of 8 to 12% depending on location. Several large trials and systematic reviews have shown progestogens to be effective in preventing or delaying preterm birth in selected high risk women with a singleton pregnancy (including those with...
Autores principales: | Norman, Jane E, Shennan, Andrew, Bennett, Phillip, Thornton, Steven, Robson, Stephen, Marlow, Neil, Norrie, John, Petrou, Stavros, Sebire, Neil, Lavender, Tina, Whyte, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495662/ https://www.ncbi.nlm.nih.gov/pubmed/22866909 http://dx.doi.org/10.1186/1471-2393-12-79 |
Ejemplares similares
-
Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial
por: Norman, Jane Elizabeth, et al.
Publicado: (2016) -
Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2—a study protocol
por: Norman, Jane E, et al.
Publicado: (2018) -
Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta‐analysis including data from the OPPTIMUM study
por: Romero, R., et al.
Publicado: (2016) -
Preterm birth prevention—Time to PROGRESS beyond progesterone
por: Norman, Jane E., et al.
Publicado: (2017) -
Evaluation of the Arabin cervical pessary for prevention of preterm birth in women with a twin pregnancy and short cervix (STOPPIT-2): An open-label randomised trial and updated meta-analysis
por: Norman, Jane E., et al.
Publicado: (2021)